Ann: Annual Report to shareholders, page-29

Hello,
annual report issued in adata 8 May 2018 (useful day to read the time limit of the last options in the hands of managers and in fact there are substantial changes and new parameters).
in brief summary report of the Treagus according to the protocol provided for the annual report, in fact, summarizing the salient points of 2017 up to today.
important news emerged is that Neuren has formalized a partnership interested in finalizing phase 3 Rett and start FX as the first steep of the agreement, then evolution of the collaboration for the rest including NNZ-2591 with inevitable change of control of the company.
for the potential partnerships and evolutions of the same I consider the work of Hottod of great interest, otherwise I pay attention to the numbers and innovations that have emerged in the annual that should regulate the market.
We predict that both Treagus and Glass continue to be holders of abundant 1 million per share of ordinary shares and keep good company with those already known by Scott.
since yesterday, all the other managers have gained the opportunity to convert their options into shares, but the 50% constraint remains to close a partnership or an opening of a phase 3 trial and for the remaining 50% the achievement of an objective on the market in terms of price, which however can now be found, which in 2017 was modified by executives who for 2.5 million options accept maturation up to 1 September 2018 or earlier date to be determined by the directors themselves; in this passage there is the clear sign that the now certain partnership agreements have also affected these terms.
on the market the stock is controlled and well managed by Lanstead which guarantees trading at 3 $ and which still has more than 6.6 million shares, strengthened by Walker's great guarantee that freezes its stock in 18, 2 million shares (bearing witness that at this stage and for the near future it is much more important to have weight than the value of shares).
as an indication of the tranquility of those who are the owners of Neuren actions at this stage, an invitation to reflect on the parameters on which the agreement between Neuren and Lanstead is based; The annual report certifies that Neuren estimates that it will receive approximately 8.5 million dollars in the 18-month contract and that this will be guaranteed by a Benchmark price set at $ 1.77; as a matter of fact that Neuren has been trading for about six months for about six months, I can safely say that the market fully embraces all the initiatives that favor financing through Landstead and what good they can bring. in short, full confidence of the market and of those who have supported the work of this company for years.
with this post I'm sorry to disappoint those who expected to make the most of the profit soon.